My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Banks Kick Off Earnings Season On Wednesday:...
Starbucks Shines, QSR Faces Challenges: BofA'...
US Global Investors Shines In 2024: JETS ETF...
Amazon Rolls Out A New Supermarket Chain In A...
LA Braces For More 'Extreme Fire Weather,' Mu...
US Electric Vehicle Sales Hit Record 1.3 Mill...
CFPB Sues Capital One Over Alleged $2 Billion...
Apple And Nvidia Supplier Taiwan Semiconducto...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    TEMA ETF TRUST ONCOLOGY ETF (NASDAQ: CANC)

    Overview
    current price
    $24.28
    $24.28
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    24.28
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    0.02 M
    1 day
    0.00 - 0.00
    52 weeks
    23.97 - 30.11
    p/e
    0.00
    beta
    0.0000
    market cap
    0.06 B
    dividend yield
    2.03%
    Industry
    -
    CANC by TradingView
    News and Commentary
    Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For... In September, Biden unveiled a $240 million investment to combat cancer, augmenting the administration's "Cancer Moonshot", an initiative with an array of new health resources.
    StockTwits
    StockTwits
    Most Shared
    Rivian's Strong Deliveries, R2 Line Plans And VW JV Expansion Drive Analyst Optimism
    Apple's iPhone 16 Stumbles On 'Intelligence' Awareness, But Pro Max Shines Bright: Analyst
    BoFA Expects Delta to Maintain 10% EPS Growth in 2025, Sees Strong Q4 Result
    Most Popular
    Tesla Analysts On Deliveries: EV Stock Could Have 'Stormy Weather' In Short Term, 'Generational Set Of Growth Opportunities' Long Term
    JetBlue Fined $2 Million For 'Chronic Flight Delays': Delta, United Rank Among Most On-Time Airlines
    Toyota 2024 US Sales Surge 3.7%, Hits Milestone With Over A Million Electrified Vehicles Sold
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Google
    Tesla
    Covid19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2025 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?